Role of endogenous nitric oxide in airway microvascular leakage induced by inflammatory mediators

European Respiratory Journal

Volumn 10, Issue 1, 1997, Pages 13-19

  Kageyama, N ^a   Miura, M ^a   Ichinose, M ^a   Tomaki, M ^a   Ishikawa, J ^a   Ohuchi, Y ^a   Endoh, N ^a   Shirato, K ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

airway plasma leakage; leukotriene D4; neurokinin 1 receptor; nitric oxide synthase inhibitor; substance P

Indexed keywords

6 ANILINO 5,8 QUINOLINEQUINONE; GUANYLATE CYCLASE INHIBITOR; HISTAMINE; LEUKOTRIENE D4; N BENZYL N2 [4 HYDROXY 1 [(1 METHYL 1H INDOL 3 YL)CARBONYL]PROLYL] N METHYL 3 (2 NAPHTHYL)ALANINAMIDE; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; SUBSTANCE P; TACHYKININ RECEPTOR ANTAGONIST;

AIRWAY PRESSURE; ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; ASTHMA; EXTRAVASATION; GUINEA PIG; HISTOLOGY; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL;

AMINOQUINOLINES; ANIMALS; ARGININE; ASTHMA; CAPILLARY PERMEABILITY; COLORING AGENTS; DIPEPTIDES; ENZYME INHIBITORS; EVANS BLUE; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; GUANYLATE CYCLASE; GUINEA PIGS; HISTAMINE; INDOLES; INFLAMMATION MEDIATORS; INJECTIONS, INTRAVENOUS; LEUKOTRIENE D4; LUNG; MALE; MICROCIRCULATION; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; ORGANOMETALLIC COMPOUNDS; RECEPTORS, NEUROKININ-1; SUBSTANCE P;

EID: 0031027311     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.97.10010013     Document Type: Article

References (31)

1. Persson CGA. Plasma exudation and asthma. Lung 1988; 166: 1-23.
2. Barnes PJ, Chung KF, Page CP. Inflammatory mediators and asthma. Pharmacol Rev 1988; 40: 49-84.
3. Kimura K, Inoue H, Ichinose M, et al. Bradykinin causes airway hyperresponsiveness and enhances maximal airway narrowing: role of microvascular leakage and airway edema. Am Rev Respir Dis 1992; 146: 1301-1305.
4. McDonald DM. Endothelial gaps and permeability of venules in rat tracheas exposed to inflammatory stimuli. Am J Physiol 1994; 266: L61-L83.
5. Ignarro LJ. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 1989; 65: 1-21.
6. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109-142.
7. Oliver JA. Endothelium-derived relaxing factor contributes to the regulation of endothelial permeability. J Cell Physiol 1992; 151: 506-511.
8. Kubes P, Granger DN. Nitric oxide modulates microvascular permeability. Am J Physiol 1992; 262 (Suppl. 31): H611-H615.
9. Hughes SR, Williams TJ, Brain SD. Evidence that endogenous nitric oxide modulates oedema formation induced by substance P. Eur J Pharmacol 1990; 191: 481-484.
10. Ialenti A, Ignaro A, Moncada S, Rosa MD. Modulation of acute inflammation by endogenous nitric oxide. Eur J Pharmacol 1992; 211: 177-182.
11. Mayhan WG. Role of nitric oxide in modulating permeability of hamster cheek pouch in response to adenosine 5′-diphosphate and bradykinin. Inflammation 1992; 16: 295-305.
12. Teixeira MM, Williams TJ, Hellewell PG. Role of prostaglandins and nitric oxide in acute inflammatory reactions in guinea-pig skin. Br J Pharmacol 1993; 110: 1515-1521.
13. Kuo H-P, Liu S, Barnes PJ. The effect of endogenous nitric oxide on neurogenic plasma exudation in guinea-pig airways. Eur J Pharmacol 1992; 221: 385-388.
14. Miura M, Ichinose M, Kageyama N, et al. Endogenous nitric oxide modifies antigen-induced microvascular leakage in sensitized guinea-pig airways. J Allergy Clin Ilmmunol 1996; 98: 144-151.
15. Moncada S, Higgs A. The L-arginine/nitric oxide pathway. N Engl J Med 1992; 327: 511-515.
16. Rees DD, Palmer RMJ, Schulz R, Hodson HF, Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 1990; 101: 746-752.
17. 1 receptor antagonist, FK888. Br J Pharmacol 1992; 107: 785-789.
18. 4-induced airway responses. Eur Respir J 1996; 9: 486-492.
19. Nakajima N, Ichinose M, Takahashi T, et al. Bradykinin-induced airway inflammation: contribution of sensory neuropeptides differs according to airway site. Am J Respir Crit Care Med 1994; 149: 694-698.
20. Rogers DF, Boschetto P, Barnes PJ. Plasma exudation: correlation between Evans blue dye and radiolabeled albumin in guinea-pig airways in vivo. J Pharmacol Methods 1989; 21: 309-315.
21. Rees DD, Palmer RMJ, Moncada S. Nitric oxide and the microcirculation. In: Moncada S, Higgs EA, eds. Nitric oxide from L-arginine: a bioregulatory system. Amsterdam, Elsevier, 1990; pp. 427-437.
22. McDonald DM. Neurogenic inflammation in the rat trachea. J Neurocytol 1988; 17: 583-603.
23. Ziehe M, Morbidelli L, Parenti A, Amerini S, Granger HJ, Maggi CA. Substance P increases cyclic GMP levels on coronary postcapillary venular endothelial cells. Life Sci 1993; 53: 229-234.
24. Hirayama Y, Lei Y-H, Barnes PJ, Rogers DF. Effects of two novel tachykinin antagonists, FK224 and FK888, on neurogenic airway plasma exudation, bronchoconstriction and systemic hypotension in guinea-pigs in vivo. Br J Pharmacol 1993; 108: 844-851.
25. 1 receptor activation in rats. J Auton Pharmacol 1993; 13: 193-199.
26. Mülsch A, Lückhoff A, Pohl U, Busse R, Bassenge E. LY83583 (6-anilino-5, 8-quinolinedione) blocks nitro-vasodilator-induced cyclic GMP increases and inhibition of platelet activation. Naunyn Sch Arch Pharmacol 1989; 340: 119-125.
27. Brandt MA, Conrad KP. In vivo and in vitro studies of a putative inhibitor of cyclic guanosine 3′,5′-monophosphate production. Proc Soc Exp Biol Med 1991; 196: 30-35.
28. Kubes P. Nitric oxide-induced microvascular permeability alterations: a regulatory role for cGMP. Am J Physiol 1992; 265: H1909-H1915.
29. Mayhan WG. Nitric oxide accounts for histamine-induced increases in macromolecular extravasation. Am J Physiol 1994; 266: H2369-H2373.
30. Ichinose M, Nakajima N, Takahashi T, Yamauchi H, Inoue H, Takishima T. Protection against bradykinin-induced bronchoconstriction in asthmatic patients by neurokinin receptor antagonist. Lancet 1992; 340: 1248-1251.
31. McFadden ER, Gilbert IA. Asthma. N Engl J Med 1992; 327: 1928-1937.